These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23430711)

  • 1. Influence of minor displacements in loops of the porcine parvovirus VP2 capsid on virus-like particles assembly and the induction of antibody responses.
    Pan Q; He K; Wang Y; Wang X; Ouyang W
    Virus Genes; 2013 Jun; 46(3):465-72. PubMed ID: 23430711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chimeric Porcine Parvovirus VP2 Virus-like Particles with Epitopes of South African Serotype 2 Foot-and-Mouth Disease Virus Elicits Specific Humoral and Cellular Responses in Mice.
    Li Q; Ma X; Shen Y; Dai J; Nian X; Shang X; Chen J; Wubshet AK; Zhang J; Zheng H
    Viruses; 2024 Apr; 16(4):. PubMed ID: 38675963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large-scale manufacture of VP2 VLP vaccine against porcine parvovirus in Escherichia coli with high-density fermentation.
    Wang J; Liu Y; Chen Y; Wang A; Wei Q; Liu D; Zhang G
    Appl Microbiol Biotechnol; 2020 May; 104(9):3847-3857. PubMed ID: 32130468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunogenicity of the virus-like particles derived from the VP2 protein of porcine parvovirus.
    Hua T; Zhang D; Tang B; Chang C; Liu G; Zhang X
    Vet Microbiol; 2020 Sep; 248():108795. PubMed ID: 32827923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of adenovirus-derived porcine parvovirus-like particles displaying B and T cell epitopes of foot-and-mouth disease.
    Pan Q; Wang H; Ouyang W; Wang X; Bi Z; Xia X; Wang Y; He K
    Vaccine; 2016 Jan; 34(4):578-585. PubMed ID: 26685093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel recombinant pseudorabies virus expressing parvovirus VP2 gene: Immunogenicity and protective efficacy in swine.
    Chen Y; Guo W; Xu Z; Yan Q; Luo Y; Shi Q; Chen D; Zhu L; Wang X
    Virol J; 2011 Jun; 8():307. PubMed ID: 21679423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of Postweaning Multisystemic Wasting Syndrome-Associated Clinical Symptoms by Virus-Like Particle Vaccine Against Porcine Parvovirus and Porcine Circovirus Type 2.
    Liu G; Qiao X; Chang C; Hua T; Wang J; Tang B; Zhang D
    Viral Immunol; 2020; 33(6):444-456. PubMed ID: 32255758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Construction and immunogenicity of recombinant porcine parvovirus-like particles with somatostatin].
    Zhang X; Zheng Q; Chen J; Xue G; Hou H; Hou J
    Sheng Wu Gong Cheng Xue Bao; 2010 Aug; 26(8):1057-67. PubMed ID: 21090109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of immune responses induced by porcine parvovirus virus-like particles and inactivated vaccine.
    Tian W; Qiu Z; Cui Y; Zhang J; Ma X; Cui S; Zheng S
    Pak J Pharm Sci; 2019 Jan; 32(1(Special)):377-382. PubMed ID: 30852473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Co-expression of CSFV T cell epitope E290 peptide and PPV VP2 protein in Lactobacillus casei and determination of specific antibodies in immunized mice].
    Xu YG; Cui LC; Ge JW; Zhao LL; Li YJ
    Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):667-72. PubMed ID: 17944369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of recombinant porcine parvovirus-like particles as an antigen carrier formed by the hybrid VP2 protein carrying immunoreactive epitope of porcine circovirus type 2.
    Pan Q; He K; Huang K
    Vaccine; 2008 Apr; 26(17):2119-26. PubMed ID: 18378364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
    Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
    J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capsid assembly is regulated by amino acid residues asparagine 47 and 48 in the VP2 protein of porcine parvovirus.
    Wang J; Liu Y; Chen Y; Zhang T; Wang A; Wei Q; Liu D; Wang F; Zhang G
    Vet Microbiol; 2021 Feb; 253():108974. PubMed ID: 33433338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porcine parvovirus capsid protein expressed in Escherichia coli self-assembles into virus-like particles with high immunogenicity in mice and guinea pigs.
    Ji P; Liu Y; Chen Y; Wang A; Jiang D; Zhao B; Wang J; Chai S; Zhou E; Zhang G
    Antiviral Res; 2017 Mar; 139():146-152. PubMed ID: 28063996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immune Response of Recombinant Pseudorabies Virus rPRV-VP2 Expressing VP2 Gene of Porcine Parvovirus in Mice].
    Fu P; Pan X; Han Q; Yang X; Zhu Q; Guo X; Zhang Y; Chen H
    Bing Du Xue Bao; 2016 Mar; 32(2):195-202. PubMed ID: 27396164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a recombinant pseudorabies virus expressing porcine parvovirus VP2 protein and porcine IL-6.
    Zheng HH; Wang LQ; Fu PF; Zheng LL; Chen HY; Liu F
    Virol J; 2020 Feb; 17(1):19. PubMed ID: 32014014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of recombinant porcine parvovirus virus-like particles in Saccharomyces cerevisiae and development of virus-specific monoclonal antibodies.
    Tamošiūnas PL; Petraitytė-Burneikienė R; Lasickienė R; Akatov A; Kundrotas G; Sereika V; Lelešius R; Žvirblienė A; Sasnauskas K
    J Immunol Res; 2014; 2014():573531. PubMed ID: 25045718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-assembly of virus-like particles of canine parvovirus capsid protein expressed from Escherichia coli and application as virus-like particle vaccine.
    Xu J; Guo HC; Wei YQ; Dong H; Han SC; Ao D; Sun DH; Wang HM; Cao SZ; Sun SQ
    Appl Microbiol Biotechnol; 2014 Apr; 98(8):3529-38. PubMed ID: 24413974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Construction of the eukaryotic expression vector with IL-2 gene and VP2 gene of PPV and research on immunogenicity].
    Cui BA; Wei ZY; Wang XB; Huang KH; Jin XX; Dong ZJ; Zheng LL
    Sheng Wu Gong Cheng Xue Bao; 2006 May; 22(3):425-30. PubMed ID: 16755922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide presentation on primate erythroparvovirus 1 virus-like particles: In vitro assembly, stability and immunological properties.
    Del Carmen Morán-García A; Rivera-Toledo E; Echeverría O; Vázquez-Nin G; Gómez B; Bustos-Jaimes I
    Virus Res; 2016 Sep; 224():12-8. PubMed ID: 27523978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.